A PHASE 2, MULTI-CENTER, OPEN-LABEL, DOSE-FINDING TRIAL TO INVESTIGATE THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF OPC-41061 IN PATIENTS WITH CHRONIC RENAL FAILURE UNDERGOING HEMODIALYSIS OR HEMODIAFILTRATION: